Previous close | 0.4900 |
Open | 0.3500 |
Bid | 0.3400 |
Ask | 0.5400 |
Strike | 2.00 |
Expiry date | 2025-01-17 |
Day's range | 0.3500 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 657 |
GERMANTOWN, Md., January 05, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).
GERMANTOWN, Md., November 09, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel Healthcare Conference in New York, NY.
GERMANTOWN, Md., November 08, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2022.